M. Kuş, Perihan Öztürk, A. Doğramacı, M. Güner, Yemliha Bozkurt, H. Nazik, M. Mülayim
{"title":"新冠肺炎对银屑病患者生物治疗的影响:双中心回顾性研究","authors":"M. Kuş, Perihan Öztürk, A. Doğramacı, M. Güner, Yemliha Bozkurt, H. Nazik, M. Mülayim","doi":"10.5336/dermato.2021-86216","DOIUrl":null,"url":null,"abstract":"Objective: The aim of our study is to evaluate the status of continuation of treatment of our patients who received biologic treatment during the pandemic and how they were affected by coronavirus disease-2019 (COVID-19). Material and Methods: The clinical processes of patients with moderate-severe plaque psoriasis who were treated with biologics between March 2020 and February 2021 were evaluated.","PeriodicalId":39132,"journal":{"name":"Turkiye Klinikleri Dermatoloji","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The Effects of COVID-19 on Psoriasis Patients Using Biologic Treatment: Two-Center Retrospective Study\",\"authors\":\"M. Kuş, Perihan Öztürk, A. Doğramacı, M. Güner, Yemliha Bozkurt, H. Nazik, M. Mülayim\",\"doi\":\"10.5336/dermato.2021-86216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: The aim of our study is to evaluate the status of continuation of treatment of our patients who received biologic treatment during the pandemic and how they were affected by coronavirus disease-2019 (COVID-19). Material and Methods: The clinical processes of patients with moderate-severe plaque psoriasis who were treated with biologics between March 2020 and February 2021 were evaluated.\",\"PeriodicalId\":39132,\"journal\":{\"name\":\"Turkiye Klinikleri Dermatoloji\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkiye Klinikleri Dermatoloji\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5336/dermato.2021-86216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkiye Klinikleri Dermatoloji","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/dermato.2021-86216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
The Effects of COVID-19 on Psoriasis Patients Using Biologic Treatment: Two-Center Retrospective Study
Objective: The aim of our study is to evaluate the status of continuation of treatment of our patients who received biologic treatment during the pandemic and how they were affected by coronavirus disease-2019 (COVID-19). Material and Methods: The clinical processes of patients with moderate-severe plaque psoriasis who were treated with biologics between March 2020 and February 2021 were evaluated.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
